Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 11;86(19):1684-1700.
doi: 10.1016/j.jacc.2025.07.041.

Using Transmitral Pressure Gradients and Residual Mitral Regurgitation to Optimize Outcome After Transcatheter Edge-to-Edge Repair

Affiliations
Free article

Using Transmitral Pressure Gradients and Residual Mitral Regurgitation to Optimize Outcome After Transcatheter Edge-to-Edge Repair

Hiroshi Tsunamoto et al. J Am Coll Cardiol. .
Free article

Abstract

Background: Although reducing mitral regurgitation (MR) after mitral transcatheter edge-to-edge repair (M-TEER) improves outcomes, the impact of increased transmitral mean pressure gradient (TMPG) remains controversial.

Objectives: This study aimed to evaluate the clinical significance of MR reduction and TMPG elevation in patients with functional mitral regurgitation (FMR) after M-TEER.

Methods: A total of 2,360 FMR patients were evaluated using postdischarge echocardiography after M-TEER. The relationship between TMPG and outcomes was assessed using spline analysis and group-based comparisons. Based on residual MR severity and TMPG, patients were categorized into 5 groups to assess the prognostic impact of postprocedural hemodynamics: MR ≤ mild and TMPG <5 mm Hg (n = 1,702), MR ≤ mild and TMPG ≥5 to <10 mm Hg (n = 164), moderate MR and TMPG <5 mm Hg (n = 361), moderate MR and TMPG ≥5 to <10 mm Hg (n = 71), and MR > moderate or TMPG 10 mm Hg (n = 62). The primary endpoint was all-cause death or heart failure hospitalization.

Results: The 2-year primary endpoint event rates increased progressively with higher TMPG, from 25.0% at 1 mm Hg to 47.0% at 6 mm Hg. In multivariable analysis, TMPG per 1 mm Hg increment was independently associated with the primary endpoint (HR: 1.10; 95% CI: 1.02-1.17; P = 0.008). Using MR ≤ mild as the reference, moderate MR was not linked to higher risk, whereas MR > moderate remained a significant predictor of primary endpoint. The patients with MR ≤ mild and TMPG <5 mm Hg had the lowest incidence of the primary endpoint among the 5 groups (28.4%, 39.0%, 33.0%, 43.7%, 48.4%; P < 0.001). However, event risk was not significantly different between patients with moderate MR and TMPG <5 mm Hg and those with MR ≤ mild and TMPG <5 mm Hg (HR: 1.13; 95% CI: 0.92-1.41; P = 0.24). Failure to achieve MR ≤ mild and TMPG <5 mm Hg was associated with larger left atrial volume index, greater effective regurgitation orifice area, elevated baseline TMPG, and old-generation G2 device use.

Conclusions: In patients with FMR, elevated TMPG was consistently associated with higher risks of the primary endpoint. Mild or moderate residual MR with low TMPG was associated with more favorable prognosis, suggesting that balancing MR reduction and TMPG may help refine risk stratification after M-TEER. (Japanese Registry study of valvular heart diseases treatment and prognosis; UMIN000023653).

Keywords: functional mitral regurgitation; mitral valve transcatheter edge-to-edge repair; residual mitral regurgitation; transmitral mean pressure gradient.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures The OCEAN-Mitral registry, which is part of the OCEAN-SHD (Optimized Catheter Valvular Intervention-Structural Heart Disease) registry, is supported by Edwards Lifesciences, Medtronic Japan, Boston Scientific, Abbott Medical Japan, and the Daiichi-Sankyo Company. Drs Yamamoto, Kagase, Saji, Izumi, Asami, Enta, Shirai, Izumo, Mizuno, Watanabe, Amaki, Kodama, Bota, Ohno, Hachinohe, Ueno, Kubo, and Hayashida served as clinical proctors of TEER for Abbott Medical. Drs Yamamoto, Kagase, Sugiura, Shimura, Saji, Izumi, Asami, Enta, Shirai, Izumo, Mizuno, Watanabe, Amaki, Kodama, Otsuki, Naganuma, Bota, Ohno, Hachinohe, Ueno, Nakazawa, Kubo, and Hayashida has received lecturer/consultant/advisor fees from Abbott Medical. All other authors have reported that they have no relationships relevant to the content of this paper to disclose.

LinkOut - more resources